AstraZeneca plc Could Help You Retire Early

Retirement may not be so long away for shareholders in AstraZeneca plc (LON: AZN). Here’s why…

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If, like me, you think that the stock market is looking rather high at the moment and could be due a fall, AstraZeneca (LSE: AZN) (NYSE: AZN.US) could be a great company to add to your portfolio.

The reason is that it has a relatively low beta. Indeed, AstraZeneca’s beta is just 0.8, which means that for every 10% fall in the FTSE 100, AstraZeneca should fall 8% (in theory). This would mean that your potential losses from a ‘correction’, ‘bear market or ‘fall’ (or whatever else you’d like to call a setback in the stock market) could be lessened by investing in AstraZeneca.

Of course, the reverse is also true. For every 10% rise in the stock market, AstraZeneca should only go up by 8% (in theory). However, this reduced overall volatility may be rewarded over the long run via higher demand for shares, meaning AstraZeneca could demand a more generous long term valuation as a result. This would be positive for your retirement plans.

In addition, the vast majority of AstraZeneca’s products are patent protected. This provides the company with a significant amount of protection with regards to its revenue visibility. In other words, AstraZeneca is more likely to meet revenue guidance because demand for its drugs is likely to remain and, since it is currently the only producer of the drugs, its revenue should be relatively easy to predict over the short to medium term.

In times of panic and fear, such stability and visibility are generally sought by investors, making the likes of AstraZeneca popular in downturns. Should the stock market fall, your portfolio may be boosted by the inclusion of AstraZeneca.

Furthermore, AstraZeneca could help retirement come that little bit sooner because it trades on a relatively high free cash flow yield, which provides evidence that shares are good value at current prices. A free cash flow yield of 8.9% is extremely high for a large-cap stock like AstraZeneca and it would be of no great surprise for this to fall in future years, with the share price potentially moving in the opposite direction.

Of course, an upward movement would be great news for investors in the stock and could mean their retirement days come sooner than expected.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Peter owns shares in AstraZeneca.

More on Investing Articles

Young mixed-race couple sat on the beach looking out over the sea
Dividend Shares

Here’s how (and why) I’d invest £200 a month in UK shares to target a second income of £19,251!

Using practical examples, this writer explains how he believes investing £200 a month could help him generate over £19,000 in…

Read more »

Investing Articles

10%+ yield? Here’s my 5-year Legal & General dividend forecast!

With a dividend yield approaching double digits, our writer plans to hang on to his Legal & General shares. He…

Read more »

Young woman holding up three fingers
Micro-Cap Shares

This is one of the hottest stocks in the market and it only costs 3p

The UK stock market is throwing up some amazing opportunities for investors at the moment. And one doesn’t need a…

Read more »

Investing Articles

All above 8%, which of the FTSE 250’s top 10 dividend stocks by yield is the ‘best’?

There are plenty of stocks on the FTSE 250 that have generous dividend yields. Our writer looks for those offering…

Read more »

Electric cars charging at a charging station
Investing Articles

Should I buy Tesla stock before 10 October?

Tesla stock investors are gearing up for one of the company's biggest and most anticipated product launches in its history.

Read more »

Investing Articles

Greggs shares have tumbled 10%. Is this now a wonderful opportunity to buy?

Through luck or skill, our writer managed to bank some juicy profit before Greggs shares fell. Is he considering buying…

Read more »

Playful senior couple in aprons dancing and smiling while preparing healthy dinner at home
Investing Articles

Forget the FTSE 100. Small-cap dividend stocks may be better for passive income!

Looking to make an above-average income from UK dividend stocks? Buying small-cap shares could be the way to go, research…

Read more »

Investing Articles

6.7% yield! Here’s the dividend forecast for HSBC shares through to 2026

HSBC shares are currently a great passive income option. Let's see if this is likely to continue by looking at…

Read more »